| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.008 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.1 | 0.008 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.092 | 0.008 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.083 | 0.009 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.01 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |